Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit
Source: SeekingAlpha
2025-05-28 09:35:41 ET
More on related stocks:
- Tempus AI: Firing On All Cylinders
- Agenus: Big On BOT/BAL As Cash Burn And Catalysts Collide
- Sell Tempus AI Stock Before The Cooldown Hits
- Ocugen wins FDA rare pediatric disease status for genetic eye disorder treatment
- CRISPR partners with Sirius Therapeutics for siRNA therapies
Read the full article on Seeking Alpha
For further details see:
Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit
SELLAS Life Sciences Group Inc.
NASDAQ: SLS
SLS Trading
20.38% G/L:
$6.97 Last:
7,820,479 Volume:
$6.48 Open:
SLS Latest News
May 12, 2026 04:05:00 pm
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
March 19, 2026 04:05:00 pm
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
SLS Stock Data
$535,597,063
140,448,048
1.12%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
